Description

Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. According to a report by StrategyHelix, the global stem cell treatments for cancer market is set to increase by US$ 2,209.6 million during 2022-2028, growing at a CAGR of 11.8% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for stem cell treatments for cancer. The global stem cell treatments for cancer market is segmented on the basis of cancer type, and region. On the basis of cancer type, the global stem cell treatments for cancer market has been segmented into bone cancer, brain cancer, breast cancer, colorectal cancer, leukemia, lung cancer, melanoma, others. The breast cancer segment held the largest revenue share in 2021. Geographically, the global stem cell treatments for cancer market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). Among these, North America was accounted for the highest revenue generator in 2021.

The global stem cell treatments for cancer market is highly competitive. The report also includes the profiles of leading companies such as apceth Biopharma GmbH, Benitec Biopharma Ltd., BioNTech SE, Caladrius Biosciences Inc., Celgene Corporation, ExCellThera Inc., Fluxion Biosciences Inc., Gamida-Cell Ltd, Genexine Inc., ImmunoCellular Therapeutics Ltd., OncoCyte Corporation, OncoMed Pharmaceuticals Inc., Pluristem Therapeutics Inc., SELLAS Life Sciences Group Inc., Sphere Fluidics Limited, ViaCyte Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the stem cell treatments for cancer market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Cancer type: bone cancer, brain cancer, breast cancer, colorectal cancer, leukemia, lung cancer, melanoma, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global stem cell treatments for cancer market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Stem cell treatments for cancer market overview
Part 3. Market breakdown by cancer type
– Bone cancer
– Brain cancer
– Breast cancer
– Colorectal cancer
– Leukemia
– Lung cancer
– Melanoma
– Others
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– apceth Biopharma GmbH
– Benitec Biopharma Ltd.
– BioNTech SE
– Caladrius Biosciences, Inc.
– Celgene Corporation
– ExCellThera Inc.
– Fluxion Biosciences, Inc.
– Gamida-Cell Ltd
– Genexine, Inc.
– ImmunoCellular Therapeutics, Ltd.
– OncoCyte Corporation
– OncoMed Pharmaceuticals, Inc.
– Pluristem Therapeutics Inc.
– SELLAS Life Sciences Group, Inc.
– Sphere Fluidics Limited
– ViaCyte, Inc.
About StrategyHelix
Disclaimer